July/August 2007

A collection of cancer statistics and facts

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing farther in pursuit of knowledge and new discoveries. In this issue we highlight presentations from the 43rd annual ASCO meeting as well as research being done at Massachusetts General Hospital and Dana-Farber Cancer Institute in Boston and the University of Texas Southwestern Medical Center in Dallas.

Physicians' Financial News focuses on newsworthy and/or notable companies i the oncology/biotech sector. In this issue: 1) GlaxoSmithKline 2) Ventana Medical Systems Inc. and Roche Holding AG 3) Pfizer Inc. 4) Celgene Corporation 5) Coley Pharmaceutical Group, Inc.

Among the articles provided in this issue are topics presented at the 43rd annual meeting of the American Society of Clinical Oncology: 1) Spain: When Two "Mabs" Are Better Than One 2) United Kingdom: Evidence Mounts Against Use of Adjuvant External Beam Radiotherapy in Endometrial Cancer 3) Norway: Clinical Data Suggest Potential Versatility of Pemetrexed for Injection (Alimta)-Based Regimens in Lung Cancer 4) Germany: An Anti-Inflammatory Approach to Inducing Remission in Metastatic Prostate Cancer

In this issue we highlight topics presented at the 43rd annual meeting of the American Society of Clinical Oncology: 1) Focus Groups and Advisory Boards: To What Extent Do They Supplement Oncologists' Income? 2) The High Overhead Cost of Complying With National Guidelines Other topics covered include: 1) Research Budgets Not Keeping Pace With Inflation, Cancer Advances May Suffer 2) New National Cancer Network Seeks to Improve Care Quality 3) Non-Hodgkin�s Lymphoma Guidelines Updated 4) Genetic Test May Be Unnecessary if Children Receive Lower Dose 5) Alternative to Colonoscopy Studied for Colon Cancer Screening

According to the U.S. National Cancer Institute, there are 19,000 new cases of primary brain cancer diagnosed each year. The five-year survival rate is around 30%. Brain cancers can strike all ages, and are the leading cause of cancer deaths in children under the age of 20.

This issue of Oncology & Biotech News presents some of the most noteworthy and newsworthy information from the 43rd annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.